April 25, 2023 FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials read more
March 23, 2023 Accelerating Drug Approval with Simoa®: Ultrasensitive Measurement of Biomarkers read more
December 19, 2022 New Alzheimer’s Blood Tests May Be Game-Changers for Treating the Disease read more
March 24, 2023 Multiple Sclerosis Biomarkers: The Future of Disease Detection and Management read more